The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), VASOSTRICT Injection 40 Units per 100 mL and 20 Units per 100 mL of PH Health Limited
The Product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Norepinephrine Bitartratein 5% Dextrose of Baxter Healthcare Corp
The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), KENGREAL of Chiesi USA
Cenexi reports an EBITDA breakeven for the quarter
Emcure Pharmaceuticals successfully completes USFDA PAI of Oncology facility
J B Chemicals and Pharmaceuticals receives ANDA approval for Amitriptyline Hydrochloride Tablets from USFDA
This Product is indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension
The company expects to launch this product through its marketing partner in the near future
Our Q3 FY25 revenue was at Rs. 1,384.1 crore with an EBITDA of Rs. 360 crore resulting in a 26% EBITDA margin
Morepen Laboratories approves hiving off of medical devices business
Subscribe To Our Newsletter & Stay Updated
